536456 — R J Biotech Balance Sheet
0.000.00%
Consumer DefensivesBalancedMicro Cap
Annual balance sheet for R J Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | -0.167 | 0.224 | -0.024 | 0.513 | 0.122 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 179 | 106 | 78.3 | 23.1 | 2.77 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 315 | 243 | 221 | 36.3 | 2.9 |
| Net Property, Plant And Equipment | 18.4 | 17.5 | 17.2 | 17.5 | 15.3 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 351 | 278 | 254 | 58.6 | 19.2 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 390 | 432 | 450 | 427 | 484 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 449 | 491 | 509 | 470 | 523 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -98.1 | -213 | -255 | -412 | -503 |
| Total Liabilities & Shareholders' Equity | 351 | 278 | 254 | 58.6 | 19.2 |
| Total Common Shares Outstanding |